Is Sutro Biopharma, Inc. (STRO) a Buy, Sell, or Hold?
NASDAQ : STRO
Sutro Biopharma, Inc. — Analyst Ratings
$21.3 USD
-$3.74 (-14.94%)
- Volume
- 1.43M
- Average Volume
- 315.1K
- Market Capitalization
- $206.13M
- P/E Ratio
- -1.22
- Dividend Yield
- 0.00%
- Price Target
- $50.00
- Year High
- $43.85
- Year Low
- $7.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $26.35
Analyst Consensus Summary
Consensus Rating
Sell
20 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-57.4%
vs Current Price
Price Target
$50.00
Average TargetPrice Target Range
Lowest Target
$43.00
-50.5% DOWNSIDE
Average Target
$50.00
Median Estimate
Highest Target
$60.00
-64.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 20
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 18 | 1 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Stifel Nicolaus | Laura Prendergast | $48 | $24.15 | 2026-08-06 08:08 PM | 98.8% |
| Barclays | Lukas Shumway | $56 | $29.69 | 2026-05-28 03:36 AM | 88.6% |
| H.C. Wainwright | Andrew Fein | $50 | $38.42 | 2026-05-15 06:16 AM | 30.1% |
| Bank of America Securities | Tazeen Ahmad | $12 | $36.05 | 2024-10-11 03:01 AM | -66.7% |
| H.C. Wainwright | Andrew Fein | $12 | $36.1 | 2024-10-11 02:36 AM | -66.8% |